Innate Immunotherapeutics Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Innate Immunotherapeutics Ltd with three other
companies in this sector in Australia:
Biotron Limited
(2017
sales of 1.66 million Australian Dollars [US$1.29 million]
),
OBJ Limited
(1.80 million Australian Dollars [US$1.40 million]
of which 100%
was Dermaportation & ET Technologies), and
Bioxyne Limited
(2.01 million Australian Dollars [US$1.56 million]
).
Sales Analysis.
Innate Immunotherapeutics Ltd reported sales of A$1.83 million (US$1.42 million)
for the
fiscal
year ending
March of 2017.
This
represents
a
decrease of 20.2%
versus 2016, when the company's sales were A$2.29 million.